Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
出版年份 2020 全文链接
标题
Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-06
DOI
10.1038/s41598-020-73680-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The multiplex model of the genetics of Alzheimer’s disease
- (2020) Rebecca Sims et al. NATURE NEUROSCIENCE
- LRP1 is a master regulator of tau uptake and spread
- (2020) Jennifer N. Rauch et al. NATURE
- Relationship between Surgery under General Anesthesia and the Development of Dementia: A Systematic Review and Meta-Analysis
- (2020) Je Jin Lee et al. Biomed Research International
- Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death
- (2020) Mengyu Liu et al. MOLECULAR NEUROBIOLOGY
- Anthraquinone Derivative Reduces Tau Oligomer Progression by Inhibiting Cysteine-Cysteine Interaction
- (2019) Carlos Areche et al. ChemistryOpen
- Traumatic Brain Injury as a Risk Factor for Dementia and Alzheimer’s Disease: Critical Review of Study Methodologies
- (2019) Amelia Hicks et al. JOURNAL OF NEUROTRAUMA
- Anticholinergic Drug Exposure and the Risk of Dementia
- (2019) Carol A. C. Coupland et al. JAMA Internal Medicine
- Chronic Traumatic Encephalopathy: A Brief Overview
- (2019) Arman Fesharaki-Zadeh Frontiers in Neurology
- Ageing as a risk factor for neurodegenerative disease
- (2019) Yujun Hou et al. Nature Reviews Neurology
- Amyloid-β-independent regulators of tau pathology in Alzheimer disease
- (2019) Rik van der Kant et al. NATURE REVIEWS NEUROSCIENCE
- Unconventional Secretion Mediates the Trans-cellular Spreading of Tau
- (2018) Taxiarchis Katsinelos et al. Cell Reports
- Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy
- (2018) Lucia Montenegro et al. Nanomaterials
- Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges
- (2018) Ha Nguyen et al. Pharmaceutics
- Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
- (2018) Mathias Jucker et al. NATURE NEUROSCIENCE
- Molecular Pathogenesis of the Tauopathies
- (2018) Jürgen Götz et al. Annual Review of Pathology-Mechanisms of Disease
- The Possibility of an Infectious Etiology of Alzheimer Disease
- (2018) Ghulam M. Ashraf et al. MOLECULAR NEUROBIOLOGY
- Secretion of Tau via an Unconventional Non-vesicular Mechanism
- (2018) Maria Merezhko et al. Cell Reports
- Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain
- (2018) Robert A. Whittington et al. NEUROBIOLOGY OF AGING
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer’s Disease
- (2017) Norimichi Nakamura et al. JOURNAL OF ALZHEIMERS DISEASE
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case–control study
- (2017) Ming-Hsien Chou et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes
- (2017) Nadine Ait-Bouziad et al. Nature Communications
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- Neuronal activity enhances tau propagation and tau pathology in vivo
- (2016) Jessica W Wu et al. NATURE NEUROSCIENCE
- Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management
- (2016) Guillaume Airagnes et al. Current Psychiatry Reports
- No “breakthrough” in Alzheimer’s disease
- (2016) Jacqui Wise BMJ-British Medical Journal
- No “breakthrough” in Alzheimer’s disease
- (2016) Jacqui Wise BMJ-British Medical Journal
- Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau
- (2015) Muneaki Takahashi et al. ACTA NEUROPATHOLOGICA
- Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review
- (2015) Manivannan Yegambaram et al. Current Alzheimer Research
- Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
- (2015) S. Wegmann et al. EMBO JOURNAL
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice
- (2015) Eve Peeraer et al. NEUROBIOLOGY OF DISEASE
- Raloxifene for women with Alzheimer disease
- (2015) Victor W. Henderson et al. NEUROLOGY
- Acute decrease in alkaline phosphatase after brain injury: A potential mechanism for tauopathy
- (2015) Peethambaran Arun et al. NEUROSCIENCE LETTERS
- Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups
- (2015) Yoshiyuki Soeda et al. Nature Communications
- Cumulative Use of Strong Anticholinergics and Incident Dementia
- (2015) Shelly L. Gray et al. JAMA Internal Medicine
- Association between Benzodiazepine Use and Dementia: A Meta-Analysis
- (2015) GuoChao Zhong et al. PLoS One
- Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
- (2014) Julia E. Gerson et al. ACS Chemical Neuroscience
- Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates
- (2014) Benjamin Falcon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
- (2014) Katharina Tepper et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein Interaction Module–assisted Function X (PIMAX) Approach to Producing Challenging Proteins Including Hyperphosphorylated Tau and Active CDK5/p25 Kinase Complex
- (2014) Dexin Sui et al. MOLECULAR & CELLULAR PROTEOMICS
- Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
- (2014) Jing L Guo et al. NATURE MEDICINE
- Benzodiazepine use and risk of Alzheimer's disease: case-control study
- (2014) S. Billioti de Gage et al. BMJ-British Medical Journal
- The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
- (2014) Cristian A Lasagna-Reeves et al. Acta Neuropathologica Communications
- The use of raloxifenein osteoporosis treatment
- (2013) Patrizia D'Amelio et al. EXPERT OPINION ON PHARMACOTHERAPY
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain homogenates from human tauopathies induce tau inclusions in mouse brain
- (2013) Florence Clavaguera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anesthesia and tau pathology
- (2013) Robert A. Whittington et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Genetics of Alzheimer Disease
- (2013) R. E. Tanzi Cold Spring Harbor Perspectives in Medicine
- The Importance of Tau Phosphorylation for Neurodegenerative Diseases
- (2013) Wendy Noble et al. Frontiers in Neurology
- Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability
- (2012) Katharina Flach et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies
- (2012) Carlo Ballatore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Translocator Protein
- (2011) A. M. Scarf et al. JOURNAL OF NUCLEAR MEDICINE
- Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice
- (2011) Cristian A Lasagna-Reeves et al. Molecular Neurodegeneration
- Preparation and Characterization of Neurotoxic Tau Oligomers
- (2010) Cristian A. Lasagna-Reeves et al. BIOCHEMISTRY
- Selective estrogen receptor modulators as brain therapeutic agents
- (2010) M. A. Arevalo et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Tau pathophysiology in neurodegeneration: a tangled issue
- (2009) Tara L. Spires-Jones et al. TRENDS IN NEUROSCIENCES
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now